How does ear nerve stimulation device work?

The device uses transcutaneous autonomic neuromodulation. A handheld device by Afferent Medical Solutions uses two small clips positioned on the tragus flap cartilage in front of the ear canal to deliver mild electrical signals to autonomic nerves controlling heart rate and blood pressure. Patients can use it at home without clinic visits or surgery.

What did SCRATCH-HTN trial find?

The SCRATCH-HTN trial enrolled 63 people with uncontrolled hypertension already taking at least one medication. Treatment was safe, generally comfortable and practical for home use, but researchers found no statistically significant difference between active stimulation and sham device across the entire population.

Why were results promising in severe hypertension?

A prespecified subgroup analysis showed greater blood pressure reduction among participants with more severe hypertension who received active stimulation, suggesting the technique may work better for difficult-to-control blood pressure, requiring confirmation in larger studies.

Is the device safe and practical for home use?

Researchers reported treatment was safe and generally comfortable, with participants following the prescribed schedule of 30 minutes daily for two weeks then once per week, suggesting practical regular home use.

When will it be widely available?

Findings represent an early step rather than proof of an effective treatment. Larger clinical trials are essential to confirm effectiveness before it provides a cheap, scalable solution for millions with hypertension.

DISEASES Archives - Page 15 of 20

Cancer Awareness DISEASES

MethylScan: The New $20 Blood Test That Detects Multiple Cancers Early

Bureau NewsApril 20, 2026April 20, 2026

UCLA researchers have developed MethylScan, a breakthrough low-cost blood test that detects various cancers and liver diseases by analyzing DNA methylation patterns.

Diabetes Management DISEASES

Metformin Offers New Hope for Type 1 Diabetes Management

Bureau NewsApril 20, 2026April 20, 2026

A Garvan Institute trial shows metformin reduces insulin doses in Type 1 diabetes by 12%, offering new hope for easier disease management.

HEALTH & LIFESTYLE Health & Wellness Heart Health Wellness

Is 120 the New Gold Standard? Why Lower Blood Pressure Targets Save Lives

Bureau NewsApril 18, 2026April 17, 2026

New research indicates that targeting a systolic blood pressure below 120 mm Hg significantly reduces the risk of heart attacks and strokes

Heart Health

AI Revolutionizes Heart Risk Prediction by Measuring Fat Around the Organ

Bureau NewsApril 14, 2026April 14, 2026

Discover how AI-driven measurements of heart fat from routine scans
provide a more accurate prediction of cardiovascular disease risk

Cancer Awareness

AI Could Detect Cancer by Listening to Your Voice

Bureau NewsApril 9, 2026April 9, 2026

New research reveals how artificial intelligence can detect laryngeal cancer by analyzing subtle, hidden patterns in the human voice

Cancer Awareness

Scientists Engineer Soil Bacteria to Eat Cancerous Tumors

Bureau NewsApril 8, 2026April 8, 2026

University of Waterloo researchers are engineering soil bacteria to consume cancerous tumors from the inside, overcoming oxygen barriers through synthetic biology